Dr Louise Schaper at PSA25[/caption]
Treating hypertension – a new approach
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians.
Research has indicated that a new pharmacological...
Patients with COPD terrified of contracting COVID-19
After almost 2 years of the COVID-19 pandemic, pharmacists must emphasise the importance of maintaining lung health on World COPD Day (17 November).
Age of anxiety
Anxiety is the most common mental health condition in Australia, and research shows the pandemic has only exacerbated the issue. Are we doing enough to support those who experience it?
Resistance movement: Pharmacy’s fight against antimicrobial resistance
Antimicrobial resistance (AMR) has been ranked as serious a threat to society as terrorism. With millions of lives at risk, and trillions in GDP...
Push for pharmacists to do more in Queensland
A Queensland Government inquiry has recommended allowing pharmacists to provide some low-risk prescriptions, as well as lowering the minimum patient age requirement for pharmacist-administered...
Non-steroidal care for the treatment and management of mild eczema and...
Dermal Therapy offers a comprehensive range of clinically tested products to treat and manage the symptoms associated with mild eczema and dermatitis.
